Skip to main content

Avantor, Inc.

corporate_fare Company Profile

Avantor, Inc.

AVTR·NYSE·Basic Materials·CIK 0001722482

Avantor is a global provider of essential products and services for customers in the biopharma & healthcare, education & government, and advanced technologies & applied materials sectors. The company supports customers from the initial discovery phase through to product delivery, integrating into research, scale-up, and manufacturing activities. Avantor operates through two main business approaches. First, its VWR channel business distributes consumables and equipment to laboratories worldwide. The VWR channel includes a private label offering for over 5,000 suppliers, millions of product items from major life sciences suppliers, and value-added services provided by approximately 2,000 associates. Second, Avantor manufactures its own specialized products for life sciences and medical technology. This includes J.T. Baker high-purity chemicals, Masterflex fluid handling products, and NuSil high-purity silicone for human implants. Avantor serves over 300,000 customer locations in approximately 180 countries. The company's origins trace back to the J.T. Baker Chemical Company, founded in 1904. In 2010, Avantor was acquired by New Mountain Capital from Covidien plc.

Avantor, Inc. (NYSE:AVTR) is a publicly traded company in the Basic Materials sector. Wiseek monitors AVTR SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Avantor Reports Significant Q1 Profit Decline, Warns of High Goodwill Impairment Risk
  • Avantor Beats Q1 Adjusted EPS, Reaffirms Full-Year Guidance Amidst Organic Sales Decline
  • Avantor's Q1 Adjusted EPS of $0.17 and Sales Beat Analyst Estimates
  • Avantor Appoints New EVP & Chief Transformation Officer Amid Executive Transition
  • Avantor CFO Resigns; Interim Appointed, Company Reaffirms Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$6.55B
Net Income
-$530.2M
Diluted EPS
-$0.78
Op. Cash Flow
$623.8M
Free Cash Flow
$495M
Gross Profit
$2.14B
Operating Income
-$246.2M
Cash & Equivalents
$365.4M
Total Debt
$3.95B
Debt / Equity
0.71×
Net Margin
-8.1%
Shares Outstanding
682M sh
Source: 10-K · filed 2026-02-11 · accession 0001628280-26-007118
Browse all tickers starting with A →
$9.32 -0.07% today
52-week range · as of 2026-04-29 $7.26 – $15.93
Market cap
$6.41B
Volume
8.3M (0.8× avg)
3-mo avg 10.1M
Live data · 2026-06-14 06:17 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AVTR - Latest Insights

AVTR
Apr 29, 2026, 9:02 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.34
Real-time Price: $9.32 info
Change: +$0.9803 (+12%) info
Market Cap: $6.411B info
AVTR
Apr 29, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $9.32 info
Change: +$0.8203 (+10%) info
Market Cap: $6.411B info
AVTR
Apr 29, 2026, 6:05 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.91
Real-time Price: $9.32 info
Change: +$1.41 (+18%) info
Market Cap: $6.411B info
AVTR
Apr 23, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.70
Real-time Price: $9.32 info
Change: +$1.62 (+21%) info
Market Cap: $6.411B info
AVTR
Apr 01, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.87
Real-time Price: $9.32 info
Change: +$1.45 (+18%) info
Market Cap: $6.411B info
AVTR
Mar 27, 2026, 7:40 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $7.63
Real-time Price: $9.32 info
Change: +$1.69 (+22%) info
Market Cap: $6.411B info
AVTR
Feb 12, 2026, 5:24 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $9.17
Real-time Price: $9.32 info
Change: +$0.1503 (+2%) info
Market Cap: $6.411B info
AVTR
Feb 11, 2026, 7:40 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.87
Real-time Price: $9.32 info
Change: -$0.5497 (-6%) info
Market Cap: $6.411B info
AVTR
Feb 11, 2026, 7:34 AM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $9.83
Real-time Price: $9.32 info
Change: -$0.5097 (-5%) info
Market Cap: $6.411B info